• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

MOLECULAR-BIOLOGICAL APPROACHES TO HEAD AND NECK CANCER AND THE CLINICAL APPLICATION

Research Project

Project/Area Number 10470359
Research Category

Grant-in-Aid for Scientific Research (B).

Allocation TypeSingle-year Grants
Section一般
Research Field Otorhinolaryngology
Research InstitutionWAKAYAMA MEDICAL UNIVERSITY

Principal Investigator

YAMANAKA Noboru  WAKAYAMA MEDICAL UNIVERSITY DEPARTMENT OF OTOLARYNGOLOGY, PROFESSOR & CHIEF, 医学部, 教授 (10136963)

Co-Investigator(Kenkyū-buntansha) YODA Junnichi  WAKAYAMA MEDICAL UNIVERSITY, DEPARTMENT OF OTOLARYNGOLOGY, INSTRUCTOR, 医学部, 助手 (10230822)
SAITO Tadahito  WAKAYAMA MEDICAL UNIVERSITY, DEPARTMENT OF OTOLARYNGOLOGY, ASSISTANT PROFESSOR, 医学部, 講師 (80205658)
Project Period (FY) 1998 – 2000
Project Status Completed (Fiscal Year 2000)
Budget Amount *help
¥10,000,000 (Direct Cost: ¥10,000,000)
Fiscal Year 2000: ¥3,300,000 (Direct Cost: ¥3,300,000)
Fiscal Year 1999: ¥2,900,000 (Direct Cost: ¥2,900,000)
Fiscal Year 1998: ¥3,800,000 (Direct Cost: ¥3,800,000)
Keywordshead and neck cancer / p53 / serum anti-p53 antibody / E-caderin / angiogenesis / vascular endothelial growth factor / VEGF / soluble E-cadherin / 可溶性E-カドヘリン / 癌抑制遺伝子 / p53 / パピロースウィルス
Research Abstract

1. Multifactorial analysis of p53 alteration in mesopharyngeal carcinoma : Immunohistological staining for the detection of p53 protein was performed. Significant overexpression was observed in 15 of 26 tumors (62%). In clinical stages III and IV, a five-year overall survival of patients with p53 overexpression was 0%, showing apparent contrast to 41.7% for the negative patients. A p53 antibody in the sera of mesopharyngeal carcinoma patients was measured by ELISA.4O% of the patients were positive for p53 antibody. Serological analysis is advantageous because it does not require tumor samples. Furthermore, it can be used for the follow-up of patients.
2. Implication of adhesion molecules, proteolytic enzymes and angiogenic factors in head and neck cancer metastasis : Study of E-cadherin expression in head and neck cancer tissues and its relation with survival rate revealed that decreased E-cadherin expression was correlated with poor prognosis. Thus, the function of E-cadherin may be cl … More osely related with metastatic activity of tumor cells. Angiogenesis is required for expansion of metastatic colonies as well as tumor growth. Cell lines derived from head and neck cancer cells showed significant production of vascular endothelial growth factor (VEGF), a most common angiogenic factor, indicating that tumor cells induce angiogenesis for their own growth. Combination of the immunohistochemical technique and computer-image analysis clearly showed that microvascular density was an important prognostic factor for distant metastasis in head and neck cancer. Suppression of E-cadherin function by anti-E-cadherin antibody upregulated the production of VEGF, which strongly support the close relationship between E-cadherin function and angiogenesis. Evaluation of soluble E-cadherin in sera of head and neck cancer patients by ELISA revealed that an increase of soluble E-cadherin closely related to poorer prognosis. The data strongly suggest that serum soluble E-cadherin may be very useful parameter predicting distant metastasis. Less

Report

(4 results)
  • 2000 Annual Research Report   Final Research Report Summary
  • 1999 Annual Research Report
  • 1998 Annual Research Report
  • Research Products

    (19 results)

All Other

All Publications (19 results)

  • [Publications] 山中昇: "頭頸部癌の遺伝子診断"癌の臨床. 44. 1173-1182 (1998)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] 山中昇: "耳鼻咽喉科領域の分子生物学,分子遺伝子学-発癌と癌遺伝子"日本耳鼻咽喉科学会誌. 101. 66-69 (1998)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] 山中昇: "近年における腫瘍免疫研究の進歩とその臨床応用"日本耳鼻咽喉科免疫アレルギー. 17. 1-7 (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] 與田順一: "中咽頭癌におけるp53の検討"口腔咽頭科. 11. 321-327 (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] 與田順一: "頭頸部癌患者における血清p53抗体の検討"日本耳鼻咽喉科免疫アレルギー. 17. 24-28 (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] 山中昇: "病理学的予後因子in CLIENT21頭頸部腫瘍"中山書店. 257-268 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] 山中昇: "鼻・副鼻腔疾患と分子生物学in CLIENT21鼻"中山書店. 84-96 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Yoda J, Tamura S, Takano I, Yamanaka N, et al: "Multifactorial analysis of p53 alteration in mesopharyngeal cancer"Jpn J StomatoPharyngol. 11. 321-327 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Yoda, Yamauchi K, Kagawa Y, Yamanaka N, et al: "Serum p53 antibody as a new clinical marker predicting prognosis in head and neck cancer"JJIAO. 17. 24-28 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Yamanaka N: "Molecular-biology and molecular genetics-Oncogenesis and oncogene"JJO (Nichijibi). 101. 66-69 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Yamanaka N: "Molecular genetics of head and neck cancer"Jpn J Cancer Clin. 44. 1173-1182 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Yamanaka N, Hirohashi Y: "Recent advances in cancer immunology and clinical applications"JJIAO. 17. 1-7 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Yamanaka N: "Pathological prognostic factors, Nomura Y, et al.eds. CLIENT21, HEAD AND NECK TUMORS"Nakayama Shoten, Tokyo. 257-268 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Yamanaka N, Tamura S: "Molecular biology in rhino-sinus diseases.Nomura Y, et al. eds.CLIENT21, NOSE"Nakayama Shoten, Tokyo. 84-96 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] 山中昇: "病理学予後因子"中山書店(分担). 257-268 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] 山中昇: "鼻副鼻腔疾患と分子生物学"中山書店(分担). 84-96 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] 山中 昇: "近年における腫瘍免疫研究の進歩とその臨床応用"耳鼻免疫アレルギー. 17(1). 1-7 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] 広橋良彦,山中昇: "非通常型の蛋白,ペプチド翻訳機序により生じた腫瘍抗原T細胞エピトープ"Annual Review免疫. 305-311 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] 山中 昇: "頭頸部癌の遺伝子診断" 癌の臨床. 44(11). 1173-1182 (1998)

    • Related Report
      1998 Annual Research Report

URL: 

Published: 1998-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi